ENTITY
Amgen Inc

Amgen Inc (AMGN US)

189
Analysis
Health Care • United States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
Exchange Announcement • 04 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 01 Aug 2026 04:03

Current Report (Form 8-K | Period ending 2026-07-29)

Exchange Announcement • 21 May 2026 04:59

Current Report (Form 8-K | Period ending 2026-05-19)

Exchange Announcement • 20 May 2026 04:08

Current Report (Form 8-K | Period ending 2026-05-19)

Exchange Announcement • 01 May 2026 04:03

Current Report (Form 8-K | Period ending 2026-04-30)

x